Production (Stage)
Mineralys Therapeutics, Inc.
MLYS
$16.12
$0.503.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.08% | -24.82% | -15.27% | -8.11% | 43.12% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 60.25% | 73.50% | -40.04% | -16.57% | -34.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 72.63% | -23.30% | -15.81% | -8.31% | 39.23% |
|
|
|||||
| Total Current Assets | 72.63% | -23.30% | -15.81% | -8.31% | 39.23% |
| Net Property, Plant & Equipment | -28.30% | -23.19% | 64.29% | -17.65% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.44% | 10.40% | 0.67% | 18.47% | 643.14% |
| Total Assets | 72.38% | -23.24% | -15.77% | -8.28% | 38.00% |
|
|
|||||
| Total Accounts Payable | -22.13% | -84.58% | 81.96% | -59.94% | 608.99% |
| Total Accrued Expenses | -8.15% | -49.79% | 5.71% | 78.61% | 51.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -8.60% | -53.24% | 10.30% | 47.87% | 83.21% |
|
|
|||||
| Total Current Liabilities | -8.60% | -53.24% | 10.30% | 47.87% | 83.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -8.60% | -53.24% | 10.30% | 47.87% | 83.21% |
|
|
|||||
| Common Stock & APIC | 38.99% | 0.67% | 0.65% | 0.63% | 32.36% |
| Retained Earnings | -13.95% | -19.30% | -28.57% | -26.25% | -25.27% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 78.58% | -19.28% | -18.33% | -11.57% | 36.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 78.58% | -19.28% | -18.33% | -11.57% | 36.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 78.58% | -19.28% | -18.33% | -11.57% | 36.03% |
|
|
|||||